Paul Tudor Jones Personalis, Inc. Transaction History

Tudor Investment Corp Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.78 - $3.64 $42,488 - $86,886	23,870 Added 26.33%	114,512 $227,000
Q3 2022 Nov 14, 2022	BUY	$2.89 - $5.32 $215,845 - $397,334	74,687 Added 468.11%	90,642 $269,000
Q2 2022 Aug 15, 2022	BUY	$3.27 - $8.76 $2,292 - $6,140	701 Added 4.6%	15,955 $55,000
Q1 2022 May 16, 2022	BUY	$7.56 - $14.3 $115,320 - $218,132	15,254 New	15,254 $125,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $182M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.